Abstract
Exhaled breath condensate (EBC) has emerged as a novel noninvasive technique for assessment of airway inflammation, and it also provides useful information on the airway lining fluid composition. Examples of markers that can be identified in the EBC of patients with asthma include pH, eicosanoids, nitrogen oxides and related products, markers of oxidative stress, certain cytokines, chemokines, and growth factors. There is some evidence that certain markers in EBC differ between patients with asthma and controls, and some markers may correlate with asthma severity and lung function, but there are many methodologic pitfalls with EBC assessment that limit its clinical applicability at present. More studies are needed before this technique can be recommended for clinical use.
Similar content being viewed by others
References and Recommended Reading
Mutlu GM, Garey KW, Robbins RA, et al.: Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001, 164:731–737.
Silkoff PE, Erzurum SC, Lundberg JO, et al.: ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006, 3:131–145.
Carpagnano GE, Barnes PJ, Francis J, et al.: Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation? Chest 2004, 125:2005–2010.
Kostikas K, Papatheodorou G, Ganas K, et al.: pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002, 165:1364–1370.
Leung TF, Li CY, Yung E, et al.: Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. Pediatr Pulmonol 2006, 41:87–94.
Hunt JF, Fang K, Malik R, et al.: Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000, 161:694–699.
Effors RM, Casaburi R, Su J, et al.: The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med. 2006, 173:386–392.
Hunt J, Yu Y, Burns J, et al.: Identification of acid reflux cough using serial assays of exhaled breath condensate pH. Cough 2006, 2:3–10.
Nicolaou NC, Lowe LA, Murray CS, et al.: Exhaled breath condensate pH and childhood asthma: unselected birth cohort study. Am J Respir Crit Care Med 2006, 174:254–259.
Busse WW: Leukotrienes and inflammation. Am J Respir Cirt Care Med 1998, 157:S210–S213.
Hardy CC, Robinson C, Tattersfield AE, Holgate ST: The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984, 311:209–213.
Noveral JP, Grunstein MM: Role and mechanism of thromboxane-induced proliferation of cultured airway smooth muscle cells. Am J Physiol 1992, 263:L555–L561.
Csoma Z, Kharitonov SA, Balint B, et al.: Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002, 166:1345–1349.
Montuschi P, Barnes PJ: Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002, 109:615–620.
Leung TF, Wong GW, Ko FW, et al.: Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis. Thorax 2005, 60:822–826.
Antczak A, Montuschi P, Kharitonov S, et al.: Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002, 166:301–306.
Mondino C, Ciabattoni G, Koch P, et al.: Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004, 114:761–767.
Failla M, Biondi G, Provvidenza Pistorio M, et al.: Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients. Clin Exp Allergy 2006, 36:325–330.
Lex C, Zacharasiewicz A, Payne DN, et al.: Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study. Respir Res 2006, 7:63.
Baraldi E, Carraro S, Alinovi R, et al.: Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003, 58:505–509.
Jain B, Rubinstein I, Robbins RA, et al.: Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993, 191:83–88.
Gaston B, Ratjen F, Vaughan JW, et al.: Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 2002, 165:387–390.
Corradi M, Pesci A, Casana R, et al.: Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003, 8:26–30.
Formanek W, Inci D, Lauener RP, et al.: Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002, 19:487–491.
Hanazawa T, Kharitonov SA, Barnes PJ: Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000, 162:1273–1276.
Horvath I, Hunt J, Barnes PJ, et al.: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523–548.
Chladkova J, Krcmova I, Chladek J, et al.: Validation of nitrite and nitrate measurements in exhaled brath condensate. Respiration 2006, 73:173–179.
Ratnawati, Morton J, Henry RL, Thomas PS: Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 2006, 41:929–936.
Smith AD, Cowan JO, Brassett KP, et al.: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163–2173.
Morrow JD, Roberts LJ: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 1997, 36:1–21.
Montuschi P, Corradi M, Ciabattoni G, et al.: Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999, 160:216–220.
Shahid SK, Kharitonovo SA, Wilson NM, et al.: Exhaled 8-isoprostane in childhood asthma. Respir Res 2005, 6:79.
Battaglia S, den Hertog H, Timmers MC, et al.: Small airways function and molecular markers in exhaled air in mild asthma. Thorax 2005, 60:639–644.
Montuschi P, Kharitonov SA, Ciabattoni G, et al.: Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000, 55:205–209.
Ko FW, Lau CY, Leung TF, et al.: Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:630–638.
Carpagnano GE, Kharitonov SA, Resta O, et al.: 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003, 124:1386–1392.
Mates JM, Sanchez-Jimenez F: Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999, 4:D339–D345.
Emelyanov A, Fedoseev G, Abulimity A, et al.: Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001, 120:1136–1139.
Antczak A, Nowak D, Shariati B, et al.: Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997, 10:1235–1241.
Schleiss MB, Holz O, Behnke M, et al.: The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000, 16:1115–1118.
Corradi M, Folesani G, Andreoli R, et al.: Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003, 167:395–399.
Matsunaga K, Yanagisawa S, Ichikawa T, et al.: Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 2006, 118:84–90.
Shahid SK, Kharitonov SA, Wilson NM, et al.: Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002, 165:1290–1293.
Leung TF, Wong GW, Ko FW, et al.: Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. Int Arch Allergy Immunol 2005, 137:66–72.
Ko FW, Lau CY, Leung TF, et al.: Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Clin Exp Allergy 2006, 36:44–51.
Leung TF, Wong GW, Ko FW, et al.: Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin Exp Allergy 2004, 34:786–791.
Robroeks CM, Jobsis Q, Damoiseaux JG, et al.: Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol 2006, 96:349–355.
Rosias PP, Dompeling E, Dentener MA, et al.: Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004, 38:107–114.
Effros RM. Dunning MB 3rd, Biller J, Shaker R: The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 2004, 287:L1073–L1080.
Rosias PP, Robroeks CM, Niemarkt HJ, et al.: Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 2006, [Epub ahead of print].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ko, F.W.S., Leung, T.F. & Hui, D.S.C. Are exhaled breath condensates useful in monitoring asthma?. Curr Allergy Asthma Rep 7, 65–71 (2007). https://doi.org/10.1007/s11882-007-0032-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-007-0032-0